Trial Profile
A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study Of The Efficacy and Safety Of Sildenafil Given For The Acute Treatment Of Meniere's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2021
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Meniere's disease
- Focus Therapeutic Use
- Sponsors Pfizer
- 26 Sep 2018 New trial record